Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: Sonki who wrote (172)	4/21/1998 9:29:00 PM
From: Nancy	Respond to of 641

s, wla is powerful stock but if you look at the pipeline, they dont have any potential killer drug in the pipeline. luckily they got lipitor which is eating mrk's lunch. lipitor was introduced about 12 months now so it has another 3-5 years growth before it levels off or someone else comes up another better cholestrol controll drug. in this drug business, the best drug you can have is a killer drug that is a "maintenance drug", many many refills. the potential abuse of viagra usage is worrisome but if pfe falls because of that, as wong said, would be an opp to add more - pfe's pipeline is very strong, 2 more new drugs this year and 3-5 ready for clincal trials in 1999.